Source-grounded facts extracted from Varex Imaging Corp's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Varex Imaging Corp reported third quarter of fiscal year 2026 results: revenue between $210 million and $225 million, EPS Non-GAAP net earnings per diluted share is expected to be between $0.15 and $0.30. Guidance initiated.
“Guidance for the third quarter of fiscal year 2026 is as follows: • Revenues are expected to be between $210 million and $225 million • Non-GAAP net earnings per diluted share is expected to be between $0.15 and $0.30”
Varex Imaging Corp reported second quarter fiscal year 2026 results: revenue $216 million, EPS GAAP net loss $0.19 per diluted share | Non-GAAP net income* $0.21 per diluted share. Guidance reaffirmed.
“CITY, May 7, 2026 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter fiscal year 2026. Q2FY26 Summary • Revenues $216 million • GAAP gross margin 34% | Non-GAAP gross margin* 34% • GAAP operating margin 7% | Non-GAAP operating margin* 9% • GAAP net loss $0.19 per diluted share | Non-GAAP net income*”
Varex Imaging Corp incurred credit facility of $350,000,000 with Zions Bancorporation, N.A. dba Zions First National Bank at SOFR plus a margin or an alternative base rate plus a margin maturing March 13, 2031.
“and UMB Bank, N.A. as joint lead arrangers (the “Credit Agreement”). The Credit Agreement provides for (i) a secured term loan facility in an aggregate principal amount of $350,000,000, (ii) a secured revolving credit facility in an aggregate principal amount of $100,000,000, which includes a $35,000,000 letter of credit sub‐facility and a $20,000,000 swingline”
Varex Imaging Corp terminated Revolving Credit and Guaranty Agreement with Zions Bancorporation, N.A. dba Zions First National Bank valued at Terminated senior secured revolving credit facility of up to $155,000,000 (effective 2026-03-13).
“Substantially concurrently with the closing of the Credit Agreement, on March 13, 2026, the Company terminated its Revolving Credit and Guaranty Agreement, dated as of March 26, 2024, by and among the Company, Varex Imaging West, LLC, Varex Imaging Deutschland AG, as borrowers, the guarantors party thereto, Zions Bancorporation, N.A. dba Zions First National Bank, as administrative and collateral agent, and the lenders party thereto (as amended, the “Terminated Credit Agreement”).”
Varex Imaging Corp terminated 2027 Notes Indenture with Computershare Trust Company, N.A. valued at Satisfied and discharged $368,000,000 aggregate principal amount of outstanding 7.875% Senior Secure (effective 2026-03-13).
“The 2027 Notes were issued pursuant to a Senior Secured Notes Indenture, dated as of September 30, 2020, among the Company, as issuer, the guarantors party thereto, Computershare Trust Company, N.A. (as successor to Wells Fargo Bank, National Association), as trustee and collateral agent (the “Trustee”) (as amended and supplemented, the “2027 Notes Indenture”).”
Varex Imaging Corp entered into Credit and Guaranty Agreement with Zions Bancorporation, N.A. dba Zions First National Bank valued at Secured term loan facility of $350,000,000; secured revolving credit facility of $100,000,000 with $ (effective 2026-03-13).
“On March 13, 2026, Varex Imaging Corporation (the “Company”) and certain of its subsidiaries entered into a Credit and Guaranty Agreement with, among others, the lenders and issuing banks from time to time party thereto, Zions Bancorporation, N.A. dba Zions First National Bank, as administrative agent and collateral agent, Citizens Banks, National Association and Bank of Montreal as co-documentation agents, Zions Bancorporation, N.A. dba Zions First National Bank, as lead arranger and sole bookrunner, and U.S. Bank National Association, Capital One, N.A., Fifth Third Bank, National Association and UMB Bank, N.A. as joint lead arrangers (the “Credit Agreement”).”
Varex Imaging Corp: Approved amendment to Certificate of Incorporation to include an officer exculpation provision limiting or eliminating monetary liability of certain officers for breaches of fiduciary duty of care (effective 2025-02-13).
“On February 13, 2025, at the 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of Varex Imaging Corporation (the “Company”), the Company’s stockholders approved an amendment to the Varex Imaging Corporation Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) to provide for the limitation or elimination of monetary liability of certain officers of the company for breaches of the fiduciary duty of care, to the fullest extent permitted under Delaware law (the “Amendment”).”
Varex Imaging Corp reported three and six months ended March 29, 2024 (second quarter of fiscal year 2024) results: revenue $206 million, net income GAAP net earnings $0.03 per diluted share; Non-GAAP net earnings $0.16 per diluted share. Guidance lowered.
“May 2, 2024 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2024. 2QFY24 Summary • Revenues $206 million • GAAP gross margin 32% | Non-GAAP gross margin* 33% • GAAP operating margin 4% | Non-GAAP operating margin* 6% • GAAP net earnings $0.03 per diluted share | Non-GAAP net”
Varex Imaging Corp incurred revolving credit of up to $155 million with Zions Bancorporation, N.A. DBA Zions First National Bank at SOFR plus 2.00% to 2.75% maturing September 26, 2027.
“agent, the lenders named therein, the issuing banks named therein, and Zions, as lead arranger and bookrunner, providing for a senior secured revolving credit facility of up to $155 million (the “ Credit Facility ”). Simultaneous with its entry into the Credit Facility, the Company terminated its senior secured asset-based revolving credit agreement, dated as of”
Varex Imaging Corp terminated Senior Secured Asset-Based Revolving Credit Agreement with Bank of America N.A. valued at Terminated (effective 2024-03-26).
“Simultaneous with its entry into the Credit Facility, the Company terminated its senior secured asset-based revolving credit agreement, dated as of September 30, 2020, with Bank of America N.A., as administrative and collateral agent, and the lenders named therein, providing for the asset-backed lending facility (the “ Existing Credit Facility ”).”
Varex Imaging Corp entered into Senior Secured Revolving Credit Agreement with Zions Bancorporation, N.A. DBA Zions First National Bank valued at $155 million (effective 2024-03-26).
“On March 26, 2024 , Varex Imaging Corporation (the “ Company ”), Varex Imaging West, LLC (“ VI West ”) and Varex Imaging Deutschland AG (the “ German Borrower ” and together with the Company and VI West, the “ Borrowers ”) and certain guarantors party thereto (the “ Guarantors ”) entered into a senior secured revolving credit agreement, dated as of March 26, 2024 (the “ Credit Agreement ”) with Zions Bancorporation, N.A. DBA Zions First National Bank (“ Zions ”), as administrative and collateral agent, the lenders named therein, the issuing banks named therein, and Zions, as lead arranger and bookrunner, providing for a senior secured revolving credit facility of up to $155 million (the “ Credit Facility ”).”
Varex Imaging Corp shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year 2024 at the 2024-02-08 meeting.
“The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year 2024:”
Varex Imaging Corp shareholders approved Approval of Varex Imaging Corporation 2020 Omnibus Stock Plan, as Amended and Restated at the 2024-02-08 meeting.
“The Company’s stockholders approved the Varex Imaging Corporation 2020 Omnibus Stock Plan, as Amended and Restated as described in the Proxy Statement:”
Varex Imaging Corp shareholders approved Advisory vote on compensation of named executive officers at the 2024-02-08 meeting.
“The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement:”
Varex Imaging Corp shareholders approved Election of Directors at the 2024-02-08 meeting.
“The Company’s stockholders elected Kathleen L. Bardwell, Jocelyn D. Chertoff, Timothy E. Guertin, Jay K. Kunkel, Walter M Rosebrough, Jr., Sunny S. Sanyal and Christine A. Tsingos to serve as directors until the 2025 Annual Meeting of Stockholders:”
Varex Imaging Corp reported first quarter of fiscal year 2024 results: revenue $190 million.
“Revenue of $190 million in the first quarter of fiscal 2024, was at the mid-point of our guidance, however unfavorable mix in both the Medical and Industrial segments impacted profitability.”
Varex Imaging Corp reported three months ended December 29, 2023 results: revenue $190 million.
“February 6, 2024 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter of fiscal year 2024. 1QFY24 Summary • Revenues $190 million • GAAP gross margin 30% | Non-GAAP gross margin* 31% • GAAP operating margin 2% | Non-GAAP operating margin* 5% • GAAP net loss $0.01 per diluted share | Non-GAAP net earnings*”
Varex Imaging Corp reported for the first quarter of fiscal year 2024 results: revenue $180 million to $200 million, EPS $0.00 to $0.20 per diluted share (Non-GAAP). Guidance initiated.
“Outlook The following guidance is provided for the first quarter of fiscal year 2024: • Revenues are expected to be between $180 million and $200 million • Non-GAAP net income per diluted share is expected to be between $0.00 and $0.20”
Varex Imaging Corp reported for the twelve months ended September 29, 2023 (FY23) results: revenue $893 million, EPS $1.08 per diluted share (GAAP); $1.27 per diluted share (Non-GAAP).
“FY23 Summary • Record revenues of $893 million • GAAP gross margin 32% | Non-GAAP gross margin* 33% • GAAP operating expense $213 million | Non-GAAP operating expense* $199 million • GAAP operating margin 9% | Non-GAAP operating margin* 11% • GAAP net income $1.08 per diluted share | Non-GAAP net income* $1.27 per diluted share • Cash flow from operations $108 million”
Varex Imaging Corp reported for the three months ended September 29, 2023 (Q4 FY23) results: revenue $227 million, EPS $0.66 per diluted share (GAAP); $0.45 per diluted share (Non-GAAP).
“Q4 FY23 Summary • Revenues of $227 million • GAAP gross margin 34% | Non-GAAP gross margin* 36% • GAAP operating expense $54 million | Non-GAAP operating expense* $51 million • GAAP operating margin 11% | Non-GAAP operating margin* 13% • GAAP net income $0.66 per diluted share | Non-GAAP net income* $0.45 per diluted share • Cash flow from operations $47 million”
Varex Imaging Corp reported third quarter of fiscal year 2023 results: revenue $232 million, EPS $0.21 per diluted share. Guidance reaffirmed.
“August 1, 2023 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the third quarter of fiscal year 2023. 3QFY23 Summary • Revenues $232 million • GAAP gross margin 33% | Non-GAAP gross margin* 34% • GAAP operating margin 10% | Non-GAAP operating margin* 13% • GAAP net earnings $0.21 per diluted share | Non-GAAP net”
Varex Imaging Corp reported third quarter of fiscal year 2023 results: revenue between $ 220 million and $ 240 million, EPS between $0.20 and $0.40. Guidance initiated.
“Outlook The following guidance is provided for the third quarter of fiscal year 2023: • Revenues are expected to be between $ 220 million and $ 240 million • Non-GAAP net earnings per diluted share is expected to be between $0. 20 and $0.40”
Varex Imaging Corp reported second quarter of fiscal year 2023 results: revenue $228 million, EPS $0.10 per diluted share.
“VAREX ANNOUNCES STRONG FINANCIAL RESULTS FOR SECOND QUARTER FISCAL YEAR 2023 SALT LAKE CITY, May 2, 2023 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2023. 2QFY23 Summary • Revenues $228 million • GAAP gross margin 32% | Non-GAAP gross margin* 33% • GAAP operating margin 7% | Non-GAAP operating margin* 10% • GAAP net earnings $0.10 per diluted share | Non-GAAP net earnings* $0.26 per diluted share • Cash flow from operations $27 million”
Varex Imaging Corp shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year 2023 at the 2023-02-09 meeting.
“Proposal Three : The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year 2023: For Against Abstain 37,065,082 65,152 53,597”
Varex Imaging Corp shareholders approved Advisory vote to approve the compensation of the named executive officers at the 2023-02-09 meeting.
“Proposal Two : The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement: For Against Abstain Broker Non-Votes 32,392,391 2,521,496 37,510 2,232,434”
Varex Imaging Corp shareholders approved Election of directors to serve until the 2024 Annual Meeting of Stockholders at the 2023-02-09 meeting.
“The Company’s stockholders elected Kathleen L. Bardwell, Jocelyn D. Chertoff, Timothy E. Guertin, Jay K. Kunkel, Walter M Rosebrough, Jr., Sunny S. Sanyal and Christine A. Tsingos to serve as directors until the 2024 Annual Meeting of Stockholders: For Withheld Abstain Broker Non-Votes Kathleen L. Bardwell 34,529,063 402,687 19,647 2,232,434 Jocelyn D. Chertoff 34,263,643 666,954 20,800 2,232,434 Timothy E. Guertin 34,335,506 595,510 20,381 2,232,434 Jay K. Kunkel 34,473,339 453,963 24,095 2,232,434 Walter M Rosebrough, Jr. 34,262,291 665,279 23,827 2,232,434 Sunny S. Sanyal 34,399,299 529,942 22,156 2,232,434 Christine A. Tsingos 34,048,709 883,794 18,894 2,232,434”
Varex Imaging Corp reported first quarter of fiscal year 2023 ended December 30, 2022 results: revenue $206 million, EPS $0.08. Guidance initiated.
“1QFY23 Summary • Revenues $206 million • GAAP gross margin 31% | Non-GAAP gross margin* 32% • GAAP operating expense $50 million | Non-GAAP operating expense* $47 million • GAAP operating margin 6% | Non-GAAP operating margin* 9% • GAAP net earnings $0.08 per diluted share | Non-GAAP net earnings* $0.21 per diluted share “Global demand for our products was in line with our expectations, resulting in revenue of $206 million in the first quarter,” said Sunny Sanyal, Chief Executive Officer of Varex. Sanyal added, “However, we are beginning to see some cautiousness from our customers as they assess an uncertain economic environment.” Varex’s revenue of $206 million was down 11% sequentially and up 3% year-over-year. Medical segment revenue of $160 million was down 12% sequentially and up 3% year-over-year. Industrial segment revenue of $46 million was down 9% sequentially and up 5% year-over-year. Non-GAAP gross margin was 32% in the quarter compared to 33% in the fourth quarter of fiscal”
Andrew Hartmann was appointed as Senior Vice President and General Manager, Detectors at Varex Imaging Corp.
“Andrew Hartmann, who currently serves as the Company’s Senior Vice President, Medical Sales and Marketing, will succeed Mr. Giambattista as SVP and GM, effective April 3, 2023.”
Brian Giambattista departed as Senior Vice President and General Manager, Detectors at Varex Imaging Corp.
“Brian Giambattista has advised the Company of his intention to retire as Senior Vice President and General Manager, Detectors (“SVP and GM”) of the Company, effective March 31, 2023”
Varex Imaging Corp reported the first quarter of fiscal year 2023 results: revenue between $195 million and $215 million, EPS between $0.10 and $0.30. Guidance initiated.
“The following guidance is provided for the first quarter of fiscal year 2023: • Revenues are expected to be between $195 million and $215 million • Non-GAAP net earnings per diluted share is expected to be between $0.10 and $0.30”
Varex Imaging Corp reported fiscal year 2022 results: revenue $859 million, EPS GAAP net earnings $0.73 per diluted share.
“FY22 Summary • Record revenues of $859 million • GAAP gross margin 33% | Non-GAAP gross margin* 34% • GAAP operating expense $195 million | Non-GAAP operating expense* $179 million • GAAP operating margin 10% | Non-GAAP operating margin* 13% • GAAP net earnings $0.73 per diluted share | Non-GAAP net earnings* $1.43 per diluted share”
Varex Imaging Corp reported the fourth quarter of fiscal year 2022 results: revenue $231 million, EPS GAAP net earnings $0.32 per diluted share.
“Q4 FY22 Summary • Record revenues of $231 million • GAAP gross margin 32% | Non-GAAP gross margin* 33% • GAAP operating expense $50 million | Non-GAAP operating expense* $47 million • GAAP operating margin 11% | Non-GAAP operating margin* 13% • GAAP net earnings $0.32 per diluted share | Non-GAAP net earnings* $0.42 per diluted share”
Kathleen L. Bardwell was appointed as Director at Varex Imaging Corp.
“appointed Kathleen L. Bardwell to serve on the Board for a term effective as of July 29, 2022”
Kathleen L. Bardwell was appointed as Director at Varex Imaging Corp.
“appointed Kathleen L. Bardwell to serve on the Board for a term effective as of July 29, 2022”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.